EUVIMEDEUVIMED entdecken
Crossref

Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone

Eri Kasuga, Naoko Inoshita iD, Noriaki Tanabe, Atsushi Ishida, Masataka Kato, Haruko Yoshimoto, Hideki Shiramizu, Go Matsuoka, Koji Takano, Shozo Yamada, Rimei Nishimura

Clinical Endocrinology · 2025

DOI: 10.1111/cen.15283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Eri Kasuga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Moriyama Memorial Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Thyrotropin, Neuroendocrine Tumors, Thyrotrophs. Die Arbeit nennt 15 Literaturangaben. Gefördert von: This study was supported by MHLW (grant number: 23FC1042) and MEXT KAKENHI (grant number: 19K07427)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Many patients with pituitary neuroendocrine tumours (PitNETs) containing beta (β) thyroid‐stimulating hormone (TSH)‐immunopositive cells, without syndrome of inappropriate secretion of TSH (SITSH), show a significant reduction in TSH levels following surgical removal of the tumour‐like functioning thyrotroph PitNET. We evaluated the pathophysiological and clinical characteristics of TSH‐positive cells in PIT1‐lineage PitNETs in patients without the syndrome of inappropriate secretion of TSH.

Design

Retrospective cohort study. Patients and Mesurements Overall, 165 patients diagnosed with PIT1‐lineage PitNETs without SITSH between April 2018 and July 2023 at Moriyama Memorial Hospital were reviewed. They were categorised into three groups based on the rate of βTSH‐immuno‐positive cells in their PitNETs: strongly positive group with 10% or more βTSH‐immuno‐positive cells, weakly positive group with less than 10%, and negative group. Clinical data from these groups were compared.

Results

Patient age, sex, and tumour size did not differ significantly among the groups. Most of the weakly positive cases had acromegaly, whereas many of the strongly positive cases had clinically nonfunctioning tumours. Preoperative TSH levels were slightly higher in strongly positive cases than in the other groups but fell within the normal range postoperatively, whereas postoperative TSH levels were significantly lower across all groups. The degree of TSH reduction postoperatively was significantly higher in the strongly positive group.

Conclusions

In the strongly positive group, TSH levels decreased significantly after surgery, whereas no such decrease was observed in the other two groups, suggesting that thyrotrophs in strongly positive PitNETs are TSH‐producing, similar to clinically functioning thyrotroph PitNETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsThyrotropinNeuroendocrine TumorsThyrotrophsTranscription Factor Pit-1HumansFemaleMaleRetrospective StudiesMiddle AgedAdultAged

Stichwörter der Autor:innen

hyperpituitarismimmunohistochemistryneuroendocrine tumourspituitary neoplasmsthyrotrophsthyrotropintranscription factor Pi1‐1

Substanzen

ThyrotropinTranscription Factor Pit-1

Autor:innen und Institutionen

  • Department of Pathology, Moriyama Memorial Hospital, Tokyo, Japan.
  • Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Endocrinology, Moriyama Memorial Hospital, Tokyo, Japan.
  • Department of Hypothalamic and Pituitary Surgery, Moriyama Memorial Hospital, Tokyo, Japan.

ORCID-Profile: Naoko Inoshita

Förderung

  • This study was supported by MHLW (grant number: 23FC1042) and MEXT KAKENHI (grant number: 19K07427).

Zitieren

APA

Kasuga, E., Inoshita, N., Tanabe, N., Ishida, A., Kato, M., Yoshimoto, H., Shiramizu, H., Matsuoka, G., Takano, K., Yamada, S., & Nishimura, R. (2025). Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone. Clinical Endocrinology. https://doi.org/10.1111/cen.15283

Vancouver

Kasuga E, Inoshita N, Tanabe N, Ishida A, Kato M, Yoshimoto H, et al. Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone. Clinical Endocrinology. 2025. doi:10.1111/cen.15283

BibTeX
@article{Kasuga2025,
  author = {Kasuga, Eri and Inoshita, Naoko and Tanabe, Noriaki and Ishida, Atsushi and Kato, Masataka and Yoshimoto, Haruko and Shiramizu, Hideki and Matsuoka, Go and Takano, Koji and Yamada, Shozo and Nishimura, Rimei},
  title = {Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.15283}
}
Kostenlos starten →